Michael C. Skaff - 10%+ Owner at Vivos Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Michael C. Skaff in Vivos Therapeutics, Inc.

Buys

Open market
Shares
+10,849,406
Avg price
$0.9558
Total value
+$10,370,220

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+10,849,406
Share %
100%
Total value
+$10,370,220

Reported holdings for Michael C. Skaff in Vivos Therapeutics, Inc.

Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Series A Common Stock Warrant
Shares / value
1,783,582
Estimated value
$2,389,999
Report date
31 Mar 2026
Price
$1.34
Ownership
By V-CO Investors 3 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Series A Common Stock Warrant
Shares / value
1,783,582
Estimated value
$2,389,999
Report date
31 Mar 2026
Price
$1.34
Ownership
By V-CO Investors 3 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Series B Common Stock Warrant
Shares / value
1,783,582
Estimated value
$2,389,999
Report date
31 Mar 2026
Price
$1.34
Ownership
By V-Co Investors 3 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Series B Common Stock Warrant
Shares / value
1,783,582
Estimated value
$2,389,999
Report date
31 Mar 2026
Price
$1.34
Ownership
By V-Co Investors 3 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Common Stock Purchase Warrant
Shares / value
2,749,330
Estimated value
$1,600,110
Report date
30 Jun 2026
Price
$0.5820
Ownership
By V-Co Investors 4 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
2,749,330
Estimated value
$1,600,110
Report date
30 Jun 2026
Price
$0.5820
Ownership
By V-Co Investors 4 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Pre-Funded Warrant
Shares / value
429,957
Estimated value
$576,142
Report date
31 Mar 2026
Price
$1.34
Ownership
By V-CO Investors 3 LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vivos Therapeutics, Inc.

Security class
Pre-Funded Warrant
Shares / value
429,957
Estimated value
$576,142
Report date
31 Mar 2026
Price
$1.34
Ownership
By V-CO Investors 3 LLC
Underlying class
Common Stock
Underlying amount

Transaction history for Michael C. Skaff in Vivos Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .